Friday, July 10, 2026

pharma · Primary Biliary Cirrhosis · Gastric Intestinal Metaplasia

Xijing Hospital of

Xijing Hospital of trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
2
Patents
0
Intelligence · Clinical Trials

Xijing Hospital of clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Xijing Hospital of programs — each row shows trial ID, program name, phase, status, and indication.

Xijing Hospital of trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Xijing Hospital of.

  1. Fenofibrate — Phase 3

    Clinical update
  2. Metformin — Approved

    Clinical update

Trial registry

2 studies